Table 1.
The demographic and clinical characteristics of patients with COVID-19
| Variables | All patients (n = 599) |
|---|---|
| Age (years), median (IQR) | 61 (49–68) |
| Gender, male, n (%) | 291 (48.6%) |
| Smoking, Yes, n (%) | 24 (4.0%) |
| Co-morbidities, n (%) | |
| Hypertension | 122 (20.3%) |
| Diabetes | 68 (11.3%) |
| Pulmonary diseases | 13 (2.2%) |
| Malignancy | 5 (0.8%) |
| Renal failure | 6 (1.0%) |
| Cerebrovascular diseases | 9 (1.5%) |
| Severity on admission, n (%) | |
| Moderate | 569 (95.0%) |
| Severe | 30 (5.0%) |
| RT-PCR test, median (IQR) | |
| Onset of symptom to first RT-PCR test (days) | 7 (4–11) |
| Length of viral RNA shedding (days) | 24 (19–33) |
| No. of RT-PCR tests of each patients | 5 (4–8) |
| Clinical characteristics, median (IQR) | |
| Onset of symptom to admission (days) | 10 (7–14) |
| Length of hospital stay (days) | 30 (23–40) |
| Positive rate of SARS-CoV-2 RT-PCR (weeks after onset) | |
| Week 2 | 90.2% |
| Week 3 | 59.6% |
| Week 4 | 35.4% |
| Week 5 | 20.7% |
| Week 6 | 11.5% |
| Week 7 | 5.3% |
| Week 8 | 1.0% |
| Week 9 | 0.5% |
| ≥Week 10 | 0% |
Abbreviations: COVID-19, coronavirus disease 2019; IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.